Compromised homologous recombination (HR) due to loss of BRCA1/2 is a dominant molecular feature of HGS ovarian cancer (The Cancer Genome Atlas Research Network 2011) and other epithelial malignancies (Yang et al. 2013). Here, BRCA1 is linked to ovarian cancer.